Phase II trial of 5-FU, etoposide, cisplatin (FEP) combination chemotherapy in unresectable non-small cell lung cancer | Journal of the Korean Cancer Association;: 120-130, 1991. | WPRIM

Main content 1 Search 2 Footer 3

+A A -A High contrast

Phase II trial of 5-FU, etoposide, cisplatin (FEP) combination chemotherapy in unresectable non-small cell lung cancer / 대한암학회지

Jin-Hyuk CHOI; Hyun-Cheol CHUNG; Dong-Jip KIM; Je-Yol OH; Joon CHANG; Eun-Hee KOH; Joo-Hang KIM; Jae-Kyung RHO; Sung-Kyu KIM; Won-Young LEE; Gwi-Eon KIM; John-Kyu LOH-JUHN.

Journal of the Korean Cancer Association ; : 120-130, 1991.

Article in Ko | WPRIM | ID: wpr-89489

Responsible library: WPRO

ABSTRACT

ABSTRACT

No abstract available.

Subject(s)

Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Therapy, Combination; Etoposide; Fluorouracil

Search on Google

Full text: 1 Index: WPRIM Main subject: Cisplatin / Carcinoma, Non-Small-Cell Lung / Drug Therapy, Combination / Etoposide / Fluorouracil Language: Ko Journal: Journal of the Korean Cancer Association Year: 1991 Type: Article

Search on Google

Full text: 1 Index: WPRIM Main subject: Cisplatin / Carcinoma, Non-Small-Cell Lung / Drug Therapy, Combination / Etoposide / Fluorouracil Language: Ko Journal: Journal of the Korean Cancer Association Year: 1991 Type: Article